Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H Martin

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
The American Journal of Medicine|March 6, 2012
Minimizing inappropriate medications in older populations: a 10-step conceptual frameworkIan A Scott, Leonard C Gray, Jennifer H Martin, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2020
Translational hurdles with cannabis medicinesMyfanwy Graham, Catherine J Lucas, Jennifer Schneider, et al.
Cancer Causes & Control : CCC|October 28, 2008
Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancerJennifer H Martin, M D Coory, P C Valery, et al.
Expert Review of Clinical Pharmacology|November 1, 2022
Cannabidiol drug interaction considerations for prescribers and pharmacistsMyfanwy Graham, Jennifer H Martin, Catherine J Lucas, et al.
British Journal of Clinical Pharmacology|October 14, 2015
Can paracetamol (acetaminophen) be administered to patients with liver impairment?Kelly L Hayward, Elizabeth E Powell, Katharine M Irvine, et al.
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Drugs & Aging|June 21, 2012
Effects of a drug minimization guide on prescribing intentions in elderly persons with polypharmacyIan A Scott, Leonard C Gray, Jennifer H Martin, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical PracticeMirjana Radovanovic, Peter Galettis, Alex Flynn, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
The American Journal of Medicine|March 6, 2012
Minimizing inappropriate medications in older populations: a 10-step conceptual frameworkIan A Scott, Leonard C Gray, Jennifer H Martin, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2020
Translational hurdles with cannabis medicinesMyfanwy Graham, Catherine J Lucas, Jennifer Schneider, et al.
Cancer Causes & Control : CCC|October 28, 2008
Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancerJennifer H Martin, M D Coory, P C Valery, et al.
Expert Review of Clinical Pharmacology|November 1, 2022
Cannabidiol drug interaction considerations for prescribers and pharmacistsMyfanwy Graham, Jennifer H Martin, Catherine J Lucas, et al.
British Journal of Clinical Pharmacology|October 14, 2015
Can paracetamol (acetaminophen) be administered to patients with liver impairment?Kelly L Hayward, Elizabeth E Powell, Katharine M Irvine, et al.
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Drugs & Aging|June 21, 2012
Effects of a drug minimization guide on prescribing intentions in elderly persons with polypharmacyIan A Scott, Leonard C Gray, Jennifer H Martin, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Paclitaxel and Therapeutic Drug Monitoring with Microsampling in Clinical PracticeMirjana Radovanovic, Peter Galettis, Alex Flynn, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
Pageof 19